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Misfolded glycoproteins in the endoplasmic reticulum
of a eukaryotic cell are exported to the cytosol, where
they are proteolytically degraded by the ubiquitin–pro-
teasome system. A recent study has identified a novel
E3 ubiquitin ligase that recognises target glycopro-
teins via their sugar moieties.
Many cellular processes are regulated by the degra-
dation of key proteins. Proteolysis can occur in differ-
ent ways, such as the protease cascades in apoptosis
or in specialised cellular organelles of the lyso-
some/endosome system, but the degradation of most
short-lived proteins in a eukaryotic cell is accom-
plished by the ubiquitin–proteasome system [1].
Processes regulated in this way include cell-cycle pro-
gression, transcription, signal transduction and endo-
cytosis, and the system also functions in the elim-
ination of aberrantly folded polypeptides. A recent
study [2] has provided interesting new insights into the
way in which misfolded glycoproteins of the endo-
plasmic reticulum (ER) are targeted for degradation by
the ubiquitin–proteasome system.
The proteasome is a 26S protease complex found in
both cytosol and the nucleus. Proteins targeted for pro-
teasomal degradation are usually tagged with ubiquitin,
a highly conserved, 76 residue polypeptide, which is
covalently attached to lysyl residues of the doomed
protein. Ubiquitination is catalysed by a series of
enzymes: a ubiquitin activating enzyme (E1), a ubiquitin
conjugating enzyme (E2), a ubiquitin protein ligase 
(E3) and, in some cases, a ubiquitin chain elongation
enzyme (E4). The specificity of protein ubiquitination is
conferred by the E3s, a diverse group of enzymes that
recognise the target protein substrates. While some
E3s are monomeric, most appear to be oligomers. One
particular family of oligomeric E3s are known as SCF
complexes for their subunits Skp1, Cdc53/Cullin and an
F box protein, where the F box protein is an adaptor
subunit that confers target substrate specificity [3]. A
superscript denotes the identity of the F box protein: for
example, Cdc4 is the F box subunit in the SCFCdc4
complex. F box proteins come in many different forms:
all have an approximately 45 residue F box domain, but
they are otherwise very dissimilar. The F box domain
binds to the Skp1 subunit in an SCF complex (Figure 1).
One important cellular process dependent on the
ubiquitin–proteasome system is the ER-associated
protein degradation (ERAD) pathway. Newly synthe-
sised proteins in the ER of a eukaryotic cell are
subject to a stringent quality control system. Those
proteins that fold correctly, or are assembled correctly
into appropriate oligomers, are retained in the ER or
allowed to proceed to their ultimate destination; but
those that do not fold correctly, and orphan subunits
of oligomers, are destroyed by ERAD. Such failed
proteins are exported across the ER membrane into
the cytosol, where they are ubiquitinated and degraded
by the proteasome.
Many proteins in the ER are N-glycosylated, and 
the glycans interact with resident ER lectins allow
-ing the newly synthesised glycoprotein to enter the
calnexin–calreticulin folding cycle [4]. Glycoproteins
that fail to reach their native conformation are elim-
inated by ERAD. Precisely how they are selected for
ERAD remains unclear, but what is now clear is that
trimming of the N-glycans plays a key role in the
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Figure 1. A model for the role of N-linked glycans in ERAD.
(1) A glycoprotein with permanent structural defects and carry-
ing a glycan in the form Glc0-3Man8GlcNAc2 is released from
the calnexin–calreticulin cycle [5], recognised by a mannosi-
dase-like protein (MLP) and eventually dislocated from the ER
to the cytosol. (2) Here the protein binds to the glycan-specific
F box protein Fbx2 and is targeted to the SCFFbx2-type E3 ubiq-
uitin ligase complex. (3) This results in the protein being poly-
ubiquitinated. (4) The protein is subsequently deglycosylated by
a cytosolic peptide N-glycanase (PNGase) that is closely asso-
ciated with the ubiquitin ligase complex and/or the 19S lid of
the proteasome. (5) Finally, the ubiquitinated, deglycosylated
protein is degraded by the proteasome.







































selection process [5]. In particular, recent evidence
indicates that defective glycoproteins can be targeted
to ERAD by the mannosylation state of their sugar
chains. Recognition by a mannosidase-like protein 
in the ER [6,7] decrees that the glycoprotein be
dislocated from the ER to the cytosol (Figure 1), where
it can be ubiquitinated and targeted to the protea-
some for degradation. In some cases, a cytosolic
peptide N-glycanase removes the sugar chain [8]. It is
not clear whether the sugars play any role once the
condemned protein appears in the cytosol; it is also
not known whether deglycosylation precedes, follows
or is simultaneous with ubiquitination.
Yoshida and coworkers [2] have now found one of
the missing links between glycosylation and ubiquiti-
nation. They have identified a ubiquitin ligase complex
that specifically binds N-glycosylated proteins, leading
to their ubiquitination. When mouse brain extracts
were mixed with GlcNAc-terminated fetuin (GTF)-
immobilised beads, two of the proteins that bound
were specifically eluted with N,N’-diacetylchitobiose
(chitobiose), but not with EDTA/EGTA or N-acetylglu-
cosamine. Amino acid sequence analysis identified
these proteins as Skp1 and the F box protein Fbx2,
two components of the E3 ubiquitin ligase complex,
SCFFbx2. Fbx2, but not Skp1, was found to interact
with GTF, indicating that Fbx2 mediates the interaction
between Skp1 and GTF.
The GTF-binding property of Fbx2 was mapped to
the whole carboxy-terminal domain (residues 95–296).
Fbx2, in common with other F box proteins, forms a
complex with Skp1, Cul1 and Roc1, and the recom-
binant SCFFbx2 complex was shown to ubiquinate
GTF. Ubiquitination of GTF did not occur in the absence
of SCFFbx2 or with a complex containing the different
human F box protein βTrCP1, and it was inhibited by
chitobiose and abolished when GTF was deglycosy-
lated using peptide N-glycanase. Collectively, these
data show that SCFFbx2 is an E3 ubiquitin ligase that
recognises target proteins that are N-glycosylated.
In an overlay assay, several endogenous high-
mannose-containing mouse brain glycoproteins bound
to Fbx2. The major endogenous Fbx2-binding glycopro-
tein had a molecular weight of 120 kDa and was identi-
fied as integrin β1. Binding of endogenous proteins was
inhibited by chitobiose, or by treating the proteins with
endo-β-N-acetylglucosaminidase H — which cleaves
high-mannose type oligosaccharides — and was com-
pletely abolished by peptide N-glycanase treatment.
While Fbx2 bound to both galactose-terminated asialofe-
tuin and GTF, it bound more effectively to mannose-
terminated fetuin and ribonuclease B, which has a high
mannose-containing oligosaccharide. Clearly, Fbx2
binds to sugars, most effectively to mannose.
Because high-mannose oligosaccharide-modified
proteins are found in the ER, it seems likely that
SCFFbx2 is important in ER quality control in neurons,
with a role in the ubiquitination and degradation of
ERAD substrates. Supporting this contention, known
ERAD substrates — a mutant form of the cystic fibro-
sis transmembrane conductance regulator (CFTR)
lacking phenylalanine 508 [9] and the T-cell receptor α
subunit [10] — were both shown to bind Fbx2, and
they were found to be rapidly degraded in pulse-
chase experiments. Because mutant Fbx2 with the F
box domain deleted was shown still to interact with
the ERAD substrates, it was assumed that overex-
pression of the mutant protein acts as a dominant-
negative repressor of ERAD, and this was experi-
mentally confirmed. These findings strongly suggest
that SCFFbx2 is specifically involved in the ubiquitina-
tion and degradation of misfolded glycoproteins 
that are translocated from the ER to the cytosol 
in neurons. Glycan-mediated elimination of ERAD
substrates in other cell types may depend on SCF
ubiquitin ligase complexes with different, as yet
unidentified, F box proteins.
Post-translational modification is increasingly emerg-
ing as a prerequisite for targeting proteins to the ubiq-
uitin pathway. Specific ubiquitin ligases recognise
protein modifications, such as phosphorylation and
prolyl hydroxylation [11,12]. The new work of Yoshida
and colleagues [2] shows that N-glycosylation also
plays a role in targeting ERAD substrates to the ubiqui-
tin–proteasome pathway. Specificity is conferred by the
E3 ligase complex.
Finally, if glycans are important for interaction 
with the E3 ligase complex, where does peptide 
N-glycanase, which removes glycans from proteins, fit
into the picture? A recent study [13] based on use of
the yeast two-hybrid assay has shown that cytosolic
peptide N-glycanase interacts with several proteins,
including ubiquitin, proteasome-interacting proteins
and proteasome subunits. It is possible to envisage a
scenario (Figure 1) in which the sugars serve as a signal
resulting in ubiquitin attachment, only being removed
by the glycanase after ubiquitination has occurred and
degradation by the proteasome is inevitable.
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